Proposed legislation would direct HHS to establish compensation limits and require more disclosure around payments tied to Medicare Advantage enrollment.

Judge orders defense to disclose details of mental health evidence ahead of state trial.

GLP-1 medications prescribed for obesity could generate nearly $193,000 in lifetime economic and health value per patient while delivering outsized benefits to populations that have historically faced greater barriers to weight management, according to a new working paper from the National Bureau of Economic Research.

According to the report, employer spending on GLP-1 drugs doubled in a single year, rising from $11 to $24 per member per month. GLP-1s now account for 10.5% of all prescription drug claims, up from 6.9% in 2023.

The Department of Justice has obtained a $3.4 million default judgement against a Nebraska pharmacist and pharmacy company over allegations of fraudulent billing to Medicare and Medicaid.

A federal court decision voids the fee as an unlawful tax imposed without congressional authorization, resetting compliance expectations for employers and setting up a likely appeal.

The Clear Healthcare Expense Cost Knowledge (CHECK) Act increases disclosure obligations for PBMs, TPAs and insurers while tightening billing timelines and penalties across the health care system.

Democrats warn of ACA marketplace disruption, workforce reductions and erosion of core public health programs.